In 2024, we celebrated our 25th anniversary. That's 25 years of smarter studies, global impact and better health. '25 at 25' is a series of articles highlighting 25 of our major achievements in that time.

Latest News

STOPCAP study finds that most men with advanced prostate cancer benefit from new-generation hormone therapy drugs



New results from a meta-analysis by the STOPCAP Collaboration were presented at the American Society of Clinical Oncology Genitourinary 2025 Meeting.

13 Feb

SMAART-MAP malaria trial opens for recruitment

SMAART-MAP is a platform trial testing supportive treatments added to standard treatment. The trial aims to improve short-term recovery in children hospitalised with severe malaria.

11 Feb

PIPELINE project launched: European collaboration tackles infectious diseases in pregnant people and infants


The PIPELINE project, a groundbreaking initiative aimed at enhancing preparedness and response to infections affecting pregnant people and infants across Europe, officially kicked off this week.

31 Jan

TB-CHAMP trial finds first-ever safe and effective treatment to prevent multidrug-resistant TB in children


The trial found that levofloxacin, taken for six months once daily, substantially reduced the risk of developing drug-resistant TB.

19 Dec

More News

Research Themes

Cancer cells

Cancer

Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types

 

Infections

Major international clinical trials answering questions of global public health significance

Neurodegenerative diseases

New generation of innovative multi-arm multi-stage trials to identify and test new therapeutic treatments in neurodegenerative diseases (NDD)

Methodology

Development of methods with direct impact on the design, conduct and analysis of studies

 

 

Other Research & Policy

This section will capture projects outside the current QQR themes

Latest Podcasts

 

 

Latest Videos